☰

Benjamin Ponder, Ph.D. - Publications

Affiliations: 
2007 Communication Studies Northwestern University, Evanston, IL 
Area:
Rhetoric and Composition Language, American Studies, United States History, American Literature
Tree Info Similar researchers PubMed Report error

90/174 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Campbell TM, Castro MA, de Santiago I, Fletcher MN, Halim S, Prathalingam R, Ponder BA, Meyer KB. FGFR2 risk SNPs confer breast cancer risk by augmenting estrogen responsiveness. Carcinogenesis. PMID 27236187 DOI: 10.1093/carcin/bgw065  0.34
2015 Castro MA, de Santiago I, Campbell TM, Vaughn C, Hickey TE, Ross E, Tilley WD, Markowetz F, Ponder BA, Meyer KB. Regulators of genetic risk of breast cancer identified by integrative network analysis. Nature Genetics. PMID 26618344 DOI: 10.1038/ng.3458  0.364
2013 Jones JO, Chin SF, Wong-Taylor LA, Leaford D, Ponder BA, Caldas C, Maia AT. TOX3 mutations in breast cancer. Plos One. 8: e74102. PMID 24069272 DOI: 10.1371/journal.pone.0074102  0.362
2013 Fletcher MN, Castro MA, Wang X, de Santiago I, O'Reilly M, Chin SF, Rueda OM, Caldas C, Ponder BA, Markowetz F, Meyer KB. Master regulators of FGFR2 signalling and breast cancer risk. Nature Communications. 4: 2464. PMID 24043118 DOI: 10.1038/Ncomms3464  0.335
2012 Maia AT, Antoniou AC, O'Reilly M, Samarajiwa S, Dunning M, Kartsonaki C, Chin SF, Curtis CN, McGuffog L, Domchek SM, Easton DF, Peock S, Frost D, Evans DG, ... ... Ponder BA, et al. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R63. PMID 22513257 DOI: 10.1186/bcr3169  0.332
2012 Cho HS, Toyokawa G, Daigo Y, Hayami S, Masuda K, Ikawa N, Yamane Y, Maejima K, Tsunoda T, Field HI, Kelly JD, Neal DE, Ponder BA, Maehara Y, Nakamura Y, et al. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene. International Journal of Cancer. Journal International Du Cancer. 131: E179-89. PMID 22020899 DOI: 10.1002/ijc.26501  0.308
2011 Meyer KB, Maia AT, O'Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L, Carroll J, Ponder BAJ. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression Plos Genetics. 7. PMID 21814516 DOI: 10.1371/Journal.Pgen.1002165  0.329
2011 Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, Nakamura Y, Hamamoto R. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. International Journal of Cancer. Journal International Du Cancer. 128: 562-73. PMID 20473859 DOI: 10.1002/ijc.25366  0.3
2010 Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, Brown J, Audley T, McGuffog L, Ponder BAJ, Pharoah PDP, Easton DF, Dunning AM. No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk Cancer Epidemiology Biomarkers and Prevention. 19: 1862-1865. PMID 20570912 DOI: 10.1158/1055-9965.EPI-10-0281  0.33
2010 Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 19: 2886-97. PMID 20418484 DOI: 10.1093/Hmg/Ddq174  0.403
2010 Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BAJ, Pharoah PDP, Khaw KT, Easton DF, Dunning AM. Telomere length in prospective and retrospective cancer case-control studies Cancer Research. 70: 3170-3176. PMID 20395204 DOI: 10.1158/0008-5472.CAN-09-4595  0.331
2010 Azzato EM, Lee AJX, Teschendorff A, Ponder BAJ, Pharoah P, Caldas C, Maia AT. Common germ-line polymorphism of C1QA and breast cancer survival British Journal of Cancer. 102: 1294-1299. PMID 20332777 DOI: 10.1038/sj.bjc.6605625  0.386
2010 Udler MS, Ahmed S, Healey CS, Meyer K, Struewing J, Maranian M, Kwon EM, Zhang J, Tyrer J, Karlins E, Platte R, Kalmyrzaev B, Dicks E, Field H, Maia AT, ... ... Ponder BA, et al. Fine scale mapping of the breast cancer 16q12 locus. Human Molecular Genetics. 19: 2507-15. PMID 20332101 DOI: 10.1093/Hmg/Ddq122  0.343
2009 Maia AT, Spiteri I, Lee AJX, O'Reilly M, Jones L, Caldas C, Ponder BAJ. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast Breast Cancer Research. 11. PMID 20003265 DOI: 10.1186/bcr2458  0.326
2009 Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... ... Ponder BA, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424  0.325
2009 Unoki M, Kelly JD, Neal DE, Ponder BAJ, Nakamura Y, Hamamoto R. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer British Journal of Cancer. 101: 98-105. PMID 19491893 DOI: 10.1038/sj.bjc.6605123  0.32
2009 Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, ... ... Ponder BA, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138  0.4
2009 Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, ... ... Ponder BA, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947  0.312
2009 Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodríguez R, Barbosa-Morais NL, Ponder BA, Low YL, Bingham S, Haiman CA, Le Marchand L, et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Human Molecular Genetics. 18: 1131-9. PMID 19126777 DOI: 10.1093/Hmg/Ddn429  0.377
2009 Mavaddat N, Dunning AM, Ponder BAJ, Easton DF, Pharoah PD. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer Cancer Epidemiology Biomarkers and Prevention. 18: 255-259. PMID 19124506 DOI: 10.1158/1055-9965.EPI-08-0704  0.35
2008 Kalmyrzaev B, Pharoah PDP, Easton DF, Ponder BAJ, Dunning AM. Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer Cancer Epidemiology Biomarkers and Prevention. 17: 3618-3620. PMID 19064580 DOI: 10.1158/1055-9965.EPI-08-0216  0.331
2008 Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, Folkerd E, Luben RN, Cox D, Ballinger D, Pharoah PD, Ponder BA, Dunning AM, Easton DF. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3490-8. PMID 19064566 DOI: 10.1158/1055-9965.Epi-08-0734  0.357
2008 Pooley KA, Baynes C, Driver KE, Tyrer J, Azzato EM, Pharoah PD, Easton DF, Ponder BA, Dunning AM. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3482-9. PMID 19064565 DOI: 10.1158/1055-9965.Epi-08-0594  0.377
2008 Song H, Koessler T, Ahmed S, Ramus SJ, Kjaer SK, Dicioccio RA, Wozniak E, Hogdall E, Whittemore AS, McGuire V, Ponder BA, Turnbull C, Hines S, Rahman N, et al. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Cancer Research. 68: 8837-42. PMID 18974127 DOI: 10.1158/0008-5472.Can-08-2363  0.387
2008 Mann A, Hogdall E, Ramus SJ, DiCioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Ponder BA, Kjaer SK, Gayther SA, Thompson DJ, et al. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. European Journal of Cancer (Oxford, England : 1990). 44: 2259-65. PMID 18723338 DOI: 10.1016/J.Ejca.2008.07.010  0.303
2008 Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, ... ... Ponder BA, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. Journal of the National Cancer Institute. 100: 962-6. PMID 18577746 DOI: 10.1093/Jnci/Djn190  0.382
2008 Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BAJ. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer Plos Biology. 6: 1098-1103. PMID 18462018 DOI: 10.1371/journal.pbio.0060108  0.366
2008 Mulvany F, Ponder BAJ. Breast Cancer Research - the first ten years Breast Cancer Research. 10. PMID 18341713 DOI: 10.1186/bcr1873  0.305
2008 Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BAJ, Easton DF, Pharoahm PDP, Dunning AM, Abraham J, Antoniou A, Baynes C, Benusiglio P, Blows F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population Carcinogenesis. 29: 333-341. PMID 18174243 DOI: 10.1093/carcin/bgm284  0.35
2007 Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Human Mutation. 28: 1207-15. PMID 17688236 DOI: 10.1002/Humu.20599  0.342
2007 Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, Shah M, Caldas C, Dunning A, Easton D, Ponder B, Pharoah P. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer Journal of Clinical Oncology. 25: 3015-3023. PMID 17634480 DOI: 10.1200/JCO.2006.10.0099  0.387
2007 Baynes C, Healey CS, Pooley KA, Scollen S, Luben RN, Thompson DJ, Pharoah PD, Easton DF, Ponder BA, Dunning AM. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Research : Bcr. 9: R27. PMID 17428325 DOI: 10.1186/Bcr1669  0.415
2007 Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Ponder BA, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261  0.311
2007 Samuelson DJ, Hesselson SE, Aperavich BA, Zan Y, Haag JD, Trentham-Dietz A, Hampton JM, Mau B, Chen KS, Baynes C, Khaw KT, Luben R, Perkins B, Shah M, Pharoah PD, ... ... Ponder BA, et al. Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proceedings of the National Academy of Sciences of the United States of America. 104: 6299-304. PMID 17404222 DOI: 10.1073/Pnas.0701687104  0.379
2007 Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, Gayther SA, Pharoah PD. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. Plos One. 2: e268. PMID 17342202 DOI: 10.1371/Journal.Pone.0000268  0.405
2007 Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nature Genetics. 39: 352-8. PMID 17293864 DOI: 10.1038/Ng1981  0.377
2007 Pharoah PDP, Tyrer J, Dunning AM, Easton DF, Ponder BAJ, Abraham J, Al-Zahrani A, Baynes C, Blows F, Cebrian A, Conroy D, Dew G, Driver K, Field H, Gregory K, et al. Association between common variation in 120 candidate genes and breast cancer risk Plos Genetics. 3: 0401-0406. DOI: 10.1371/journal.pgen.0030042  0.378
2007 Pharoah PDP, Ponder BAJ. The polygenic basis of breast cancer Genes and Common Diseases. 224-232. DOI: 10.1017/CBO9780511543555.016  0.336
2006 Sternlicht MD, Dunning AM, Moore DH, Pharoah PD, Ginzinger DG, Chin K, Gray JW, Waldman FM, Ponder BA, Werb Z. Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2107-14. PMID 17119035 DOI: 10.1158/1055-9965.Epi-06-0351  0.368
2006 Benusiglio PR, Pharoah PD, Smith PL, Lesueur F, Conroy D, Luben RN, Dew G, Jordan C, Dunning A, Easton DF, Ponder BA. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer. British Journal of Cancer. 95: 1689-95. PMID 17117180 DOI: 10.1038/sj.bjc.6603473  0.377
2006 Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK, Dicioccio RA, Dunning AM, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Lesueur F, Easton DF, Jacobs IJ, Ponder BA, et al. Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Research. 66: 10220-6. PMID 17047088 DOI: 10.1158/0008-5472.Can-06-2222  0.334
2006 Oestergaard MZ, Tyrer J, Cebrian A, Shah M, Dunning AM, Ponder BAJ, Easton DF, Pharoah PDP. Interactions between genes involved in the antioxidant defence system and breast cancer risk British Journal of Cancer. 95: 525-531. PMID 16868544 DOI: 10.1038/sj.bjc.6603272  0.353
2006 El-Tanani MK, Campbell FC, Crowe P, Erwin P, Harkin DP, Pharoah P, Ponder B, Rudland PS. BRCA1 suppresses osteopontin-mediated breast cancer. The Journal of Biological Chemistry. 281: 26587-601. PMID 16807234 DOI: 10.1074/Jbc.M604403200  0.364
2006 Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, Ponder BA, Kjaer SK, Pharoah PD, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis. 27: 2235-42. PMID 16774946 DOI: 10.1093/Carcin/Bgl089  0.358
2006 Lesueur F, Song H, Ahmed S, Luccarini C, Jordan C, Luben R, Easton DF, Dunning AM, Pharoah PD, Ponder BA. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population. British Journal of Cancer. 94: 1921-6. PMID 16685266 DOI: 10.1038/Sj.Bjc.6603160  0.382
2006 Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BA, Dunning AM. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 675-82. PMID 16614108 DOI: 10.1158/1055-9965.EPI-05-0679  0.337
2006 Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA. Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis. 27: 1661-9. PMID 16501248 DOI: 10.1093/Carcin/Bgi375  0.325
2006 Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Research. 66: 1225-33. PMID 16424062 DOI: 10.1158/0008-5472.Can-05-1857  0.412
2006 Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Molecular Genetics. 15: 1-10. PMID 16306136 DOI: 10.1093/Hmg/Ddi398  0.385
2005 Ponder BAJ, Antoniou A, Dunning A, Easton DF, Pharoah PDP. Polygenic inherited predisposition to breast cancer Cold Spring Harbor Symposia On Quantitative Biology. 70: 35-41. PMID 16869736 DOI: 10.1101/sqb.2005.70.029  0.368
2005 Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1828-31. PMID 16030124 DOI: 10.1158/1055-9965.EPI-04-0807  0.416
2005 Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs. Bmc Cancer. 5: 81. PMID 16029503 DOI: 10.1186/1471-2407-5-81  0.387
2005 Lesueur F, Pharoah PD, Laing S, Ahmed S, Jordan C, Smith PL, Luben R, Wareham NJ, Easton DF, Dunning AM, Ponder BA. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Human Molecular Genetics. 14: 2349-56. PMID 16000320 DOI: 10.1093/hmg/ddi237  0.429
2005 Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. International Journal of Cancer. Journal International Du Cancer. 117: 611-8. PMID 15924337 DOI: 10.1002/Ijc.21047  0.313
2005 Benusiglio PR, Lesueur F, Luccarini C, Conroy DM, Shah M, Easton DF, Day NE, Dunning AM, Pharoah PD, Ponder BA. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study. Breast Cancer Research : Bcr. 7: R204-9. PMID 15743501 DOI: 10.1186/Bcr982  0.39
2004 MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, Ponder BA, Meuth M, Bhattacharyya NP, Cox A. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. Journal of the National Cancer Institute. 96: 1866-9. PMID 15601643 DOI: 10.1093/Jnci/Dji001  0.398
2004 Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 91: 1911-5. PMID 15545966 DOI: 10.1038/Sj.Bjc.6602239  0.318
2004 Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, et al. STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1589-94. PMID 15466974  0.34
2003 Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, ... ... Ponder B, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell. 115: 523-35. PMID 14651845 DOI: 10.1016/S0092-8674(03)00930-9  0.391
2003 Jordan VC, Ponder BAJ. Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy Breast Cancer Research. 5: 281-283. PMID 14580241 DOI: 10.1186/bcr646  0.309
2003 Kuschel B, Auranen A, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 809-12. PMID 12917215  0.41
2003 Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Research. 63: 2610-5. PMID 12750287  0.366
2003 Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nature Genetics. 33: 238-44. PMID 12610533 DOI: 10.1038/Ng1107  0.336
2003 Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Research. 63: 417-23. PMID 12543797  0.337
2003 Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, ... ... Ponder BA, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. American Journal of Human Genetics. 72: 1-12. PMID 12474142 DOI: 10.1086/345310  0.307
2003 Auranen A, Spurdle AB, Chen X, Lipscombe J, Purdie DM, Hopper JL, Green A, Healey CS, Redman K, Dunning AM, Pharoah PD, Easton DF, Ponder BA, Chenevix-Trench G, Novik KL. BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk. International Journal of Cancer. 103: 427-30. PMID 12471628 DOI: 10.1002/ijc.10814  0.39
2002 Pharoah PDP, Ponder BAJ. The genetics of ovarian cancer Best Practice and Research: Clinical Obstetrics and Gynaecology. 16: 449-468. PMID 12413928 DOI: 10.1053/beog.2002.0296  0.335
2002 Tereshchenko IV, Béshém VM, Slonimskaia EM, Ponder BA, Férokh PD, Velichko SA, Shagiakhmetova RA. Investigation of mutations of BRCA1 and BRCA2 genes in 52 breast cancer patients Voprosy Onkologii. 48: 24-28. PMID 12101561  0.39
2002 Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Research. 62: 3052-7. PMID 12036913  0.316
2002 Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BAJ, Easton DF, Pharoah PDP. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer Breast Cancer Research. 4. PMID 11879560 DOI: 10.1186/bcr419  0.381
2002 Antoniou AC, Pharoah PDP, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes British Journal of Cancer. 86: 76-83. PMID 11857015 DOI: 10.1038/sj.bjc.6600008  0.385
2002 Tereschenko IV, Basham VM, Ponder BAJ, Pharoah PDP. BRCA1 and BRCA2 mutations in Russian familial breast cancer Human Mutation. 19: 184. PMID 11793480  0.347
2002 Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, ... ... Ponder BA, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proceedings of the National Academy of Sciences of the United States of America. 99: 827-31. PMID 11792833 DOI: 10.1073/Pnas.012584499  0.351
2001 Basham VM, Pharoah PD, Healey CS, Luben RN, Day NE, Easton DF, Ponder BA, Dunning AM. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis. 22: 1797-800. PMID 11698341  0.349
2001 Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genetic Epidemiology. 21: 1-18. PMID 11443730 DOI: 10.1002/gepi.1014  0.371
2001 Ponder BAJ. Cancer genetics Nature. 411: 336-341. PMID 11357140 DOI: 10.1038/35077207  0.324
2000 Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS. Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 19: 390-4. PMID 11109172 DOI: 10.1097/00004347-200010000-00017  0.352
2000 Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nature Genetics. 26: 362-4. PMID 11062481 DOI: 10.1038/81691  0.4
2000 Ponder BAJ, Day NE, Easton DF, Pharoah PDP, Lipscombe JM, Redman K, Antoniou A, Basham V, Gregory J, Gayther S, Dunning A. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases British Journal of Cancer. 83: 1301-1308. PMID 11044354  0.372
2000 Gayther SA, De Foy KAF, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, ... ... Ponder BAJ, et al. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer Cancer Research. 60: 4513-4518. PMID 10969800  0.313
2000 Russell PA, Pharoah PD, De Foy K, Ramus SJ, Symmonds I, Wilson A, Scott I, Ponder BA, Gayther SA. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. International Journal of Cancer. Journal International Du Cancer. 87: 317-21. PMID 10897034 DOI: 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B  0.307
2000 Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. Journal of the National Cancer Institute. 92: 1088-91. PMID 10880552 DOI: 10.1093/Jnci/92.13.1088  0.32
2000 Sutcliffe S, Pharoah PDP, Easton DF, Ponder BAJ, Ponder B, Easton D, Fraser G, Jacobs I, Mackay J, Twentyman P, Bishop T, Lowe D, Lakhani S, Steel M. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer International Journal of Cancer. 87: 110-117. PMID 10861460 DOI: 10.1002/1097-0215(20000701)87:1<110::Aid-Ijc16>3.0.Co;2-6  0.376
2000 Pharoah PDP, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BAJ. Familial predisposition to breast cancer in a British population: Implications for prevention European Journal of Cancer. 36: 773-779. PMID 10762751 DOI: 10.1016/S0959-8049(00)00023-X  0.348
2000 Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, ... ... Ponder BA, et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 782-9. PMID 10741697  0.356
2000 Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JDA, Ponder BAJ, Kouzarides T, Caldas C. Mutations truncating the EP300 acetylase in human cancers Nature Genetics. 24: 300-303. PMID 10700188 DOI: 10.1038/73536  0.379
2000 Seltmann M, Harrington P, Ponder BAJ, Willatt LR, Heppell-Parton AC, Anton-Culver H. A case of inv dup(8p) with early onset breast cancer Journal of Medical Genetics. 37: 70-71. PMID 10691415  0.316
2000 Healey CS, Dunning AM, Durocher F, Teare D, Pharoah PD, Luben RN, Easton DF, Ponder BA. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis. 21: 189-93. PMID 10657957  0.409
2000 Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF. Risk models for familial ovarian and breast cancer. Genetic Epidemiology. 18: 173-90. PMID 10642429 DOI: 10.1002/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R  0.383
1999 Ponder BAJ. Breast cancer research: A meeting point as well as a journal Breast Cancer Research. 1: 1.  0.305
Low-probability matches (unlikely to be authored by this person)
2006 Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D. A prospective study of neurofibromatosis type 1 cancer incidence in the UK British Journal of Cancer. 95: 233-238. PMID 16786042 DOI: 10.1038/sj.bjc.6603227  0.3
2002 Özdaǧ H, Batley SJ, Försti A, Iyer NG, Daigo Y, Boutell J, Arends MJ, Ponder BAJ, Kouzarides T, Caldas C. Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours British Journal of Cancer. 87: 1162-1165. PMID 12402157 DOI: 10.1038/Sj.Bjc.6600554  0.3
2008 Barnett GC, Shah M, Redman K, Easton DF, Ponder BAJ, Pharoah PDP. Risk factors for the incidence of breast cancer: Do they affect survival from the disease? Journal of Clinical Oncology. 26: 3310-3316. PMID 18612147 DOI: 10.1200/JCO.2006.10.3168  0.293
2001 Daigo Y, Chin SF, Gorringe KL, Bobrow LG, Ponder BAJ, Pharoah PDP, Caldas C. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: A New Approach for the Molecular Analysis of Paraffin-Embedded Cancer Tissue American Journal of Pathology. 158: 1623-1631. PMID 11337360  0.29
2004 Pharoah PDP, Dunning AM, Ponder BAJ, Easton DF. Association studies for finding cancer-susceptibility genetic variants Nature Reviews Cancer. 4: 850-860. PMID 15516958 DOI: 10.1038/nrc1476  0.29
2006 Lesueur F, Cebrian A, Robledo M, Niccoli-Sire P, Svensson KA, Pinson S, Leyland J, Whittaker J, Pharoah PD, Ponder BAJ. Polymorphisms in RET and its coreceptors and ligands as genetic modifiers of multiple endocrine neoplasia type 2A Cancer Research. 66: 1177-1180. PMID 16424056 DOI: 10.1158/0008-5472.CAN-05-2995  0.29
2009 Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, Doody DR, MacArthur S, Tyrer J, Pharoah PD, Luben R, Bernstein L, Kolonel LN, Henderson BE, Le Marchand L, ... ... Ponder BA, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Human Molecular Genetics. 18: 1692-703. PMID 19223389 DOI: 10.1093/Hmg/Ddp078  0.289
2010 Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, Jafari E, Rakhshani N, Salahi R, Semnani S, Kamangar F, Abnet CC, Ponder B, Day N, Dawsey SM, et al. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. International Journal of Epidemiology. 39: 52-9. PMID 19332502 DOI: 10.1093/Ije/Dyp161  0.287
2002 Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BAJ. Polygenic susceptibility to breast cancer and implications for prevention Nature Genetics. 31: 33-36. PMID 11984562 DOI: 10.1038/ng853  0.287
2001 Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barrière C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, ... ... Ponder BA, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis Human Molecular Genetics. 10: 3001-3007. PMID 11751682 DOI: 10.1093/Hmg/10.26.3001  0.286
2000 Aparicio SA, Caldas C, Ponder B. Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it? Genome Biology. 1. PMID 11178245  0.284
2008 Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. The New England Journal of Medicine. 358: 2796-803. PMID 18579814 DOI: 10.1056/NEJMsa0708739  0.282
2000 Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DGR, Gilbert FG, Hayes C, Jenkins JPR, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BAJ, et al. Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer Breast. 9: 72-77. DOI: 10.1054/brst.2000.0135  0.281
2000 Piver MS, Tsukada Y, Werness BA, DiCioccio RA, Whittemore AS, Ponder BA. Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecologic Oncology. 78: 166-70. PMID 10926797 DOI: 10.1006/Gyno.2000.5840  0.281
2001 Ramus SJ, Fishman A, Pharoah PD, Yarkoni S, Altaras M, Ponder BA. Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 27: 278-81. PMID 11373105 DOI: 10.1053/ejso.2000.1097  0.279
2011 Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, Tsunoda T, Field HI, Neal DE, Ponder BA, Nakamura Y, Hamamoto R. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia (New York, N.Y.). 13: 676-84. PMID 21847359 DOI: 10.1593/neo.11512  0.278
2006 Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, Healey CS, Dunning A, Doody D, Ponder B, Luben RN, Day NE, Easton D. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1502-8. PMID 16896040 DOI: 10.1158/1055-9965.EPI-05-0828  0.276
2008 Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakr J, Easton DF, Ponder BA, Jacobs I, Kjaer SK, Whittemore AS, Pearce CL, Pharoah PD, et al. The effects of common genetic variants in oncogenes on ovarian cancer survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5833-9. PMID 18794094 DOI: 10.1158/1078-0432.Ccr-08-0819  0.276
2004 Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 23: 29-34. PMID 14668547 DOI: 10.1097/01.Pgp.0000101083.35393.Cd  0.273
2013 Kang D, Cho HS, Toyokawa G, Kogure M, Yamane Y, Iwai Y, Hayami S, Tsunoda T, Field HI, Matsuda K, Neal DE, Ponder BA, Maehara Y, Nakamura Y, Hamamoto R. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis. Genes, Chromosomes & Cancer. 52: 126-39. PMID 23011637 DOI: 10.1002/gcc.22012  0.268
2003 Schnelle C, Scott E, Ponder BAJ. Breast Cancer Research: The move to introduce article-processing charges Breast Cancer Research. 5: 218-219.  0.267
2000 Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Dicioccio RA, Tsukada Y, Ponder BA, Piver MS. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Human Pathology. 31: 1420-4. PMID 11112219 DOI: 10.1016/S0046-8177(00)80014-3  0.264
2007 Ruiz-Llorente S, Montero-Conde C, Milne RL, Moya CM, Cebrián A, Letón R, Cascón A, Mercadillo F, Landa I, Borrego S, Pérez de Nanclares G, Alvarez-Escolá C, Díaz-Pérez JA, Carracedo A, Urioste M, ... ... Ponder BA, et al. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma. Cancer Research. 67: 9561-7. PMID 17909067 DOI: 10.1158/0008-5472.Can-07-1638  0.257
2000 Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DGR, Gilbert FG, Hayes C, Jenkins JPR, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BAJ, et al. Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer Breast. 9: 78-82. DOI: 10.1054/brst.2000.0136  0.257
2000 Mazoyer S, Leary J, Kirk J, Fleischmann E, Wagner T, Claes K, Messiaen L, Foulkes W, Desrochers M, Simard J, Phelan CM, Kwan E, Narod SA, Vahteristo P, Nevanlinna H, ... ... Ponder BAP, et al. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographicaly diverse populations American Journal of Human Genetics. 67: 207-212. PMID 10827109 DOI: 10.1086/302974  0.257
2015 Rajan A, Berns A, Ringborg U, Celis J, Ponder B, Caldas C, Livingston D, Bristow RG, Hecht TT, Tursz T, van Luenen H, Bono P, Helander T, Seamon K, Smyth JF, et al. Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies. Molecular Oncology. PMID 26797050 DOI: 10.1016/J.Molonc.2015.12.007  0.256
2011 Toyokawa G, Cho HS, Masuda K, Yamane Y, Yoshimatsu M, Hayami S, Takawa M, Iwai Y, Daigo Y, Tsuchiya E, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, ... Ponder BA, et al. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia (New York, N.Y.). 13: 887-98. PMID 22028615 DOI: 10.1593/neo.11048  0.252
2004 Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JGM, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, ... ... Ponder B, et al. Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers Clinical Cancer Research. 10: 2473-2481. PMID 15073127 DOI: 10.1158/1078-0432.Ccr-1029-3  0.243
2011 Toyokawa G, Cho HS, Iwai Y, Yoshimatsu M, Takawa M, Hayami S, Maejima K, Shimizu N, Tanaka H, Tsunoda T, Field HI, Kelly JD, Neal DE, Ponder BA, Maehara Y, et al. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prevention Research (Philadelphia, Pa.). 4: 2051-61. PMID 21930796 DOI: 10.1158/1940-6207.CAPR-11-0290  0.242
2000 Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Graves M, Hayes C, Jenkins JP, Jones AP, Keevil SF, Leach MO, ... ... Ponder BA, et al. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magnetic Resonance Imaging. 18: 765-76. PMID 11027869 DOI: 10.1016/S0730-725X(00)00167-3  0.241
2010 Hayami S, Yoshimatsu M, Veerakumarasivam A, Unoki M, Iwai Y, Tsunoda T, Field HI, Kelly JD, Neal DE, Yamaue H, Ponder BA, Nakamura Y, Hamamoto R. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Molecular Cancer. 9: 59. PMID 20226085 DOI: 10.1186/1476-4598-9-59  0.239
2005 Cascon A, Cebrian A, Pollan M, Ruiz-Llorente S, Montero-Conde C, Leton R, Gutierrez R, Lesueur F, Milne RL, Gonzalez-Albarran O, Lucas-Morante T, Benitez J, Ponder BA, Robledo M. Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 90: 2127-30. PMID 15623805 DOI: 10.1210/jc.2004-2059  0.235
2011 Toyokawa G, Masuda K, Daigo Y, Cho HS, Yoshimatsu M, Takawa M, Hayami S, Maejima K, Chino M, Field HI, Neal DE, Tsuchiya E, Ponder BA, Maehara Y, Nakamura Y, et al. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Molecular Cancer. 10: 65. PMID 21619671 DOI: 10.1186/1476-4598-10-65  0.224
2005 Cebrian A, Lesueur F, Martin S, Leyland J, Ahmed S, Luccarini C, Smith PL, Luben R, Whittaker J, Pharoah PD, Dunning AM, Ponder BA. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 90: 6268-74. PMID 16091499 DOI: 10.1210/Jc.2004-2449  0.219
2011 Hayami S, Kelly JD, Cho HS, Yoshimatsu M, Unoki M, Tsunoda T, Field HI, Neal DE, Yamaue H, Ponder BA, Nakamura Y, Hamamoto R. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. International Journal of Cancer. Journal International Du Cancer. 128: 574-86. PMID 20333681 DOI: 10.1002/ijc.25349  0.217
2005 Benusiglio PR, Luccarini C, Ajai O, Ponder BA, Pharoah PD. Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant. Carcinogenesis. 26: 2213. PMID 16014700 DOI: 10.1093/Carcin/Bgi181  0.206
2003 Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nature Genetics. 34: 403-12. PMID 12881723 DOI: 10.1038/Ng1220  0.205
2011 Takawa M, Masuda K, Kunizaki M, Daigo Y, Takagi K, Iwai Y, Cho HS, Toyokawa G, Yamane Y, Maejima K, Field HI, Kobayashi T, Akasu T, Sugiyama M, Tsuchiya E, ... ... Ponder BA, et al. Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Science. 102: 1298-305. PMID 21539681 DOI: 10.1111/j.1349-7006.2011.01958.x  0.203
2012 Cho HS, Hayami S, Toyokawa G, Maejima K, Yamane Y, Suzuki T, Dohmae N, Kogure M, Kang D, Neal DE, Ponder BA, Yamaue H, Nakamura Y, Hamamoto R. RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. Neoplasia (New York, N.Y.). 14: 476-86. PMID 22787429 DOI: 10.1593/neo.12656  0.197
2001 Kuschel B, Gayther SA, Easton DF, Ponder BAJ, Pharoah PDP. Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing Genes Chromosomes and Cancer. 31: 96-98. PMID 11284041 DOI: 10.1002/gcc.1122  0.188
2007 Ramus SJ, Harrington PA, Pye C, Peock S, Cook MR, Cox MJ, Jacobs IJ, DiCioccio RA, Whittemore AS, Piver MS, EMBRACE, Easton DF, Ponder BA, Pharoah PD, Gayther SA. Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online. Human Mutation. 28: 525-6. PMID 17397054 DOI: 10.1002/Humu.9493  0.187
2006 Carniti C, Belluco S, Riccardi E, Cranston AN, Mondellini P, Ponder BAJ, Scanziani E, Pierotti MA, Bongarzone I. The RetC620R mutation affects renal and enteric development in a mouse model of Hirschsprung's disease American Journal of Pathology. 168: 1262-1275. PMID 16565500 DOI: 10.2353/ajpath.2006.050607  0.185
2000 Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BAJ, Mann GJ, Bishop DT, Bishop JN. Mutation screening of the CDKN2A promoter in melanoma families Genes Chromosomes and Cancer. 28: 45-57. PMID 10738302 DOI: 10.1002/(SICI)1098-2264(200005)28:1<45::AID-GCC6>3.0.CO;2-F  0.178
2000 Knowles CH, Chir B, Gayther SA, Scott M, Ramus S, Anand P, Williams NS, Ponder BA. Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF Diseases of the Colon and Rectum. 43: 851-857. PMID 10859088  0.177
2005 Lesueur F, Cebrian A, Cranston A, Leyland J, Faid TM, Clements MR, Robledo M, Whittaker J, Ponder BAJ. Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients Journal of Clinical Endocrinology and Metabolism. 90: 3454-3457. PMID 15741265 DOI: 10.1210/jc.2004-1622  0.173
2003 Cranston AN, Ponder BAJ. Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model Cancer Research. 63: 4777-4780. PMID 12941793  0.164
2006 Ponder B. A Review of: “Ronald C. White, Jr., The Eloquent President: A Portrait of Lincoln Through His Words” The Southern Communication Journal. 71: 101-102. DOI: 10.1080/10417940500503571  0.162
2012 Liu R, Maia AT, Russell R, Caldas C, Ponder BA, Ritchie ME. Allele-specific expression analysis methods for high-density SNP microarray data. Bioinformatics (Oxford, England). 28: 1102-8. PMID 22355082 DOI: 10.1093/bioinformatics/bts089  0.161
2012 Cho HS, Shimazu T, Toyokawa G, Daigo Y, Maehara Y, Hayami S, Ito A, Masuda K, Ikawa N, Field HI, Tsuchiya E, Ohnuma S, Ponder BA, Yoshida M, Nakamura Y, et al. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nature Communications. 3: 1072. PMID 22990868 DOI: 10.1038/ncomms2074  0.161
2005 Hu SP, Day NE, Li DR, Luben RN, Cai KL, Ou-Yang T, Li B, Lu XZ, Ponder BA. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. British Journal of Cancer. 92: 967-70. PMID 15726104 DOI: 10.1038/sj.bjc.6602347  0.154
2001 Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. The Journal of Clinical Endocrinology and Metabolism. 86: 5658-71. PMID 11739416 DOI: 10.1210/jcem.86.12.8070  0.15
2006 Cranston AN, Carniti C, Oakhill K, Radzio-Andzelm E, Stone EA, McCallion AS, Hodgson S, Clarke S, Mondellini P, Leyland J, Pierotti MA, Whittaker J, Taylor SS, Bongarzone I, Ponder BA. RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. Cancer Research. 66: 10179-87. PMID 17047083 DOI: 10.1158/0008-5472.Can-06-0884  0.147
2011 Cho HS, Suzuki T, Dohmae N, Hayami S, Unoki M, Yoshimatsu M, Toyokawa G, Takawa M, Chen T, Kurash JK, Field HI, Ponder BA, Nakamura Y, Hamamoto R. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Research. 71: 655-60. PMID 21115810 DOI: 10.1158/0008-5472.CAN-10-2446  0.144
2001 Reynolds L, Jones K, Winton DJ, Cranston A, Houghton C, Howard L, Ponder BA, Smith DP. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET. Oncogene. 20: 3986-94. PMID 11494127 DOI: 10.1038/sj.onc.1204434  0.142
2012 Takawa M, Cho HS, Hayami S, Toyokawa G, Kogure M, Yamane Y, Iwai Y, Maejima K, Ueda K, Masuda A, Dohmae N, Field HI, Tsunoda T, Kobayashi T, Akasu T, ... ... Ponder BA, et al. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. Cancer Research. 72: 3217-27. PMID 22556262 DOI: 10.1158/0008-5472.CAN-11-3701  0.141
2000 Dunning AM, Durocher F, Healey CS, Teare MD, McBride SE, Carlomagno F, Xu CF, Dawson E, Rhodes S, Ueda S, Lai E, Luben RN, Van Rensburg EJ, Mannermaa A, Kataja V, ... ... Ponder BA, et al. The extent of linkage disequilibrium in four populations with distinct demographic histories. American Journal of Human Genetics. 67: 1544-54. PMID 11078480 DOI: 10.1086/316906  0.137
2000 Huen DS, Elsdon M, Ponder BA. The Drosophila Ret gene is transcribed in multiple alternatively spliced forms. Molecular & General Genetics : Mgg. 264: 335-40. PMID 11085274  0.133
1990 Maher ER, Bentley E, Yates JR, Barton D, Jennings A, Fellows IW, Ponder MA, Ponder BA, Benjamin C, Harris R. Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis. Journal of the Neurological Sciences. 100: 27-30. PMID 1982450 DOI: 10.1016/0022-510X(90)90008-B  0.131
2004 Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Journal of the National Cancer Institute. 96: 936-45. PMID 15199113  0.127
2004 Daigo Y, Takayama I, Ponder BAJ, Caldas C, Ward SM, Sanders KM, Fujino MA. Novel human, mouse and xenopus genes encoding a member of the RAS superfamily of low-molecular-weight GTP-binding proteins and its downregulation in W/WV mouse jejunum Journal of Gastroenterology and Hepatology (Australia). 19: 211-217. DOI: 10.1111/J.1440-1746.2004.03298.X  0.126
2005 Böckmann M, Hilken G, Schmidt A, Cranston AN, Tannapfel A, Drosten M, Frilling A, Ponder BAJ, Pützer BM. Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection Human Gene Therapy. 16: 1267-1275. PMID 16259560 DOI: 10.1089/hum.2005.16.1267  0.125
2005 Pharoah PDP, Dunning AM, Ponder BAJ, Easton DF. The reliable identification of disease-gene associations Cancer Epidemiology Biomarkers and Prevention. 14: 1362. PMID 15941939 DOI: 10.1158/1055-9965.EPI-05-0405  0.124
2004 Drosten M, Hilken G, Böckmann M, Rödicker F, Mise N, Cranston AN, Dahmen U, Ponder BAJ, Pützer BM. Role of MEN2A-derived RET in maintenace and proliferation of medullary thyroid carcinoma Journal of the National Cancer Institute. 96: 1231-1239. PMID 15316058 DOI: 10.1093/jnci/djh226  0.123
2000 Carlomagno F, Burnet NG, Turesson I, Nyman J, Peacock JH, Dunning AM, Ponder BAJ, Jackson SP. Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities International Journal of Cancer. 85: 845-849. PMID 10709106 DOI: 10.1002/(SICI)1097-0215(20000315)85:6<845::AID-IJC18>3.0.CO;2-C  0.119
2003 Daigo Y, Takayama I, Ponder BAJ, Caldas C, Ward SM, Sanders KM, Fujino MA. Differential gene expression in the murine gastric fundus lacking interstitial cells of Cajal Bmc Gastroenterology. 3. PMID 12795813 DOI: 10.1186/1471-230X-3-14  0.119
2006 Cranston A, Carniti C, Martin S, Mondellini P, Hooks Y, Leyland J, Hodgson S, Clarke S, Pierotti M, Ponder BAJ, Bongarzone I. A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation Molecular Endocrinology. 20: 1633-1643. PMID 16469774 DOI: 10.1210/me.2004-0447  0.115
2003 Daigo Y, Takayama I, Ponder BAJ, Caldas C, Ward SM, Sanders KM, Fujino MA. Differential gene expression profile in the small intestines of mice lacking pacemaker interstitial cells of Cajal Bmc Gastroenterology. 3. PMID 12831403 DOI: 10.1186/1471-230X-3-17  0.113
2011 Ponder B. Foreword Pre-Invasive Disease: Pathogenesis and Clinical Management. DOI: 10.1007/978-1-4419-6694-0  0.103
2013 Sepanlou SG, Etemadi A, Kamangar F, Sepehr A, Pourshams A, Poustchi H, Islami F, Sadjadi A, Nasrollahzadeh D, Semnani S, Saidi F, Abnet CC, Ponder B, Pharoah PD, Day NE, et al. The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Archives of Iranian Medicine. 16: 46-53. PMID 23273237 DOI: 013161/AIM.0014  0.089
2010 Ponder B, Shing LK. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran Archives of Iranian Medicine. 13: 457-458.  0.078
2012 Olson KM, Pfau MW, Ponder B, Wilson KH. Making the case: Advocacy and judgment in public argument Making the Case: Advocacy and Judgment in Public Argument. 1-260.  0.065
2001 Challen K, Harris HJ, Harris R, Modell B, Ponder B, Rodeck C. Confidential inquiries should be funded in clinical genetics [3] British Medical Journal. 322: 1061. PMID 11349659  0.063
2004 Hofstra RMW, Stelwagen T, Pasini B, van der Veen AY, Ponder BAJ, Nakamura Y, Romeo G, Buys CHCM. Ordering of markers in the pericentromeric region of chromosome 10 Human Genetics. 96: 116-118. PMID 7607644 DOI: 10.1007/BF00214199  0.062
2003 Weinhäusel A, Behmel A, Ponder BAJ, Haas OA, Niederle B, Gessl A, Vierhapper H, Pfragner R. Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman Endocrine Pathology. 14: 375-382. PMID 14739494 DOI: 10.1385/EP:14:4:375  0.054
2010 Guttmacher AE, McGuire AL, Ponder B, Stefánsson K. Personalized genomic information: preparing for the future of genetic medicine. Nature Reviews. Genetics. 11: 161-5. PMID 20065954 DOI: 10.1038/nrg2735  0.05
2005 Ponder B. Technicalities and personalities: An ethnographic operations manual of XYZ communications Cultural Studies - Critical Methodologies. 5: 95-102. DOI: 10.1177/1532708604268482  0.033
2017 Early DM, Maxwell KL, Ponder BB, Pan Y. Improving teacher-child interactions: A randomized control trial of Making the Most of Classroom Interactions and My Teaching Partner professional development models Early Childhood Research Quarterly. 38: 57-70. DOI: 10.1016/j.ecresq.2016.08.005  0.032
2000 Mendoza NA, Hosch HM, Ponder BJ, Carrillo V. Well . . . ah . . .: Hesitations and hedges as an influence on jurors' decisions Journal of Applied Social Psychology. 30: 2610-2621.  0.032
2003 Cai T, Hu Z, Ponder B, St. John J, Moro D. Synthesis and study of and controlled release from nanoparticles and their networks based on functionalized hydroxypropylcellulose Macromolecules. 36: 6559-6564. DOI: 10.1021/Ma030107H  0.031
2002 Ponder BL. Effects of pain in the human neonate Neurodiagnostic Journal. 42: 210-223.  0.029
2011 Payne RJ, Guinn C, Ponder B. Supporting the couple with conception challenges. The Nurse Practitioner. 36: 38-45. PMID 21768833 DOI: 10.1097/01.NPR.0000399715.09209.15  0.029
2004 Huang G, Gao J, Hu Z, St John JV, Ponder BC, Moro D. Controlled drug release from hydrogel nanoparticle networks. Journal of Controlled Release : Official Journal of the Controlled Release Society. 94: 303-11. PMID 14744482 DOI: 10.1016/J.Jconrel.2003.10.007  0.027
2004 St. John J, Moro D, Ponder B, Russell-Jones G, McTavish K, McDougal F. Hydrogel nanoparticle aggregates as tissue scaffolds with controlled drug delivery Transactions - 7th World Biomaterials Congress. 61.  0.023
2002 Ponder BL, Gleason TF, Mardjetko SM. Neurophysiologic intraoperative monitoring during percutaneous thoracolumbar kyphoplasty: A multimodality approach Neurodiagnostic Journal. 42: 103-118.  0.011
Hide low-probability matches.